Filing of Form 20-F with SEC

Summary by AI BETAClose X

AstraZeneca PLC announced on February 25, 2026, that it filed its 2025 Annual Report on Form 20-F with the US Securities and Exchange Commission on February 24, 2026. The report is accessible on the SEC and AstraZeneca's websites, and hard copies of the audited financial statements are available upon request.

Disclaimer*

Companies

AstraZeneca (AZN)
UK 100

Latest directors dealings